Lacklustre first day of trading for Otsuka
This article was originally published in Scrip
After an initial spike, shares in Otsuka Holdings closed lower than they had opened on the company's first day of trading on the Tokyo Stock Exchange, with investors apparently disappointed in the issue's early performance.
You may also be interested in...
Novel antibody-drug conjugate receives approval in Japan for second-line breast cancer, providing another push to Japanese firm’s strategic plan to build up its oncology operations.
Collaboration with fundraising Tokyo-based venture builds mid-sized firm's interest in cell-based therapies in a highly supportive regulatory environment.
New long-term clinical data with Takeda’s dengue vaccine contender show a durable response against all four serotypes and support the dosing regimen in an ongoing pivotal study.